New Recommendations on CGM Use Published Worldwide

Natalie Sainz

This is a subtitle for your new post

By Natalie Sainz


diaTribe and the Time in Range Coalition, in a global effort to raise the awareness and adoption of Time in Range and the use of continuous glucose monitors (CGM), published an article in a world-renowned medical journal that sets the standards for CGM use in clinical trials.


A new international consensus of recommendations for the standard use of continuous glucose monitoring (CGM) data in clinical trials has been published in The Lancet Diabetes & Endocrinology January issue. 


The consensus has been hailed as an essential step toward increasing the use of CGM metrics, including time in range, in clinical trials to advance potential breakthroughs in diabetes care. 

An arrow made of colorful dots points to the right

The diaTribe Foundation, Advanced Technologies & Treatments for Diabetes (ATTD), and the Time in Range Coalition led this seven-month effort to achieve international agreement. In April 2022, the three organizations gathered 33 of the world's top diabetes experts in Barcelona, Spain, to discuss these recommendations


Prof. Tadej Battelino, head of endocrinology at University Medical Centre Ljubljana and ATTD co-chair, played a key role in building the consensus and helped lead the international committee of experts.

“As diabetes technology continues to advance, the [use] of CGM data in clinical trials needs to be standardized so clinicians, scientists, and regulators across the globe can incorporate it into their decision-making to the benefit of individuals living with diabetes,” Battelino said.


Julie Heverly, diaTribe’s senior director of the Time in Range Coalition, said, “Standardizing trial collection, analysis, and reporting of CGM data will help ensure that the next generation of treatments are focused on increasing patients’ time in range and, therefore, quality of life.” 


People living with diabetes need better options to treat and manage their disease, Heverly said, adding that a CGM is an essential tool to achieve that goal since it helps individuals know if their blood glucose levels are in range, above range, or below range. 


“Increasing time in range (TIR) has been found to decrease serious and life-threatening complications, enhance daily disease management, and improve the lives of people living with diabetes,” Heverly said.

The consensus has been endorsed by eight leading diabetes organizations:


  • American Association of Clinical Endocrinology


  • American Diabetes Association (ADA)


  • Association of Diabetes Care and Education Specialists 


  • DiabetesIndia


  • European Association for the Study of Diabetes (EASD)


  • International Society for Pediatric and Adolescent Diabetes


  • Japan Diabetes Society


  • JDRF


“[This paper] is a big step forward in the field as we now have consensus on how to best assess and report on CGM data in clinical trials,” said Dr. Robert Gabbay, ADA’s chief science and medical officer. 


The recommendations also cover the specific glucose metrics researchers should evaluate and report, information on clinically relevant changes in key glucose metrics over time, and training for both trial staff and participants. 


In total, 23 recommendations are included in the publication.


While this paper will provide the diabetes research community with new and insightful guidance, it also has the potential to increase use of time in range and other CGM metrics internationally. 


Experts around the world weighed in on the importance of this consensus paper.


Dr. Sanjoy Dutta, chief scientific officer at JDRF said, “The ability to accelerate the development of life-changing therapies with [standardized] clinical recommendations for the use of CGM data in clinical trials empowers all stakeholders: researchers, clinicians, regulators, companies, payers, policy makers, and, most importantly, persons with diabetes. This is an important step in transforming type 1 diabetes outcomes and care beyond the current standard of HbA1c only.”


The importance of time in range

This consensus is a part of the efforts of the Time in Range Coalition, which has been working to advance the awareness and adoption of TIR globally as a primary glucose metric for daily management. 


“Clinicians can finally make glycemic management decisions based on personalized, actionable information and people with diabetes finally have a measure to follow on a daily and weekly basis that can help guide them not judge them,” said Dr. Richard Bergenstal, executive director of the International Diabetes Center in Minneapolis, Minnesota.


The diaTribe Foundation and Time in Range Coalition have had multiple meetings with the U.S. Food and Drug Administration (FDA) to discuss the adoption of TIR as a clinically meaningful metric, and how TIR could be used by regulatory bodies in drug labels, for example. 


The FDA has recognized the importance of CGM metrics like TIR for people with diabetes but noted that the lack of standardized collection and analysis in clinical trials has made use of TIR and other CGM metrics challenging. 


“Having guidance on how to introduce and interpret data from CGM in clinical trials in persons living with diabetes is a crucial next step for the field. CGM [demonstrates] the importance of the quality of glucose management; [not only] the level but also the stability of [blood] glucose levels [over time] and time [spent] in hypoglycemia,” said Chantal Mathieu, president of EASD and chair of European Diabetes Forum.


“When the Diabetes Control and Complications Trial (DCCT) established A1C as the gold standard for diabetes management in 1993, continuous glucose monitors were merely a dream,” states Jim Carroll, CEO of The diaTribe Foundation. 


“Today, the diabetes community benefits greatly from this exceptional technology,” he said. “This consensus is an effort to standardize the information generated and gathered by these new tools to advance the next generation of trials and therefore development of therapies that will improve the lives of people with diabetes.”   


Members of diaTribe and the Time in Range Coalition hope that this publication will show the global diabetes community the significance of CGM data and time in range in daily diabetes management. Standardizing the collection, analysis, and reporting of CGM data derived from clinical trials will accelerate the advancement of time in range as a critical metric for the development of drug therapies and will improve the care and daily lives of people with diabetes.


An advertisement for eddy care says need to see an endo ? see one from the comfort of your home !

Healthy Bites

A pizza in a pan on a wooden table
May 27, 2025
This is like a cross between an unfussy lasagna and a baked ziti: Cheesy, rich, and deeply satisfying, despite the actual absence of noodles. Even my daughter, who tends to be totally skeptical about “fake vegetable pasta dishes,” loves it. Don’t be daunted by the ribboning of the zucchini with a vegetable peeler: It honestly doesn’t take that long, and the resulting strands are thinner and wider and just generally more noodle-like than what you’d get with a spiralizer. That said, if you want to start with a pound of zoodles, go ahead – just be sure to salt and drain them really well or the resulting dish will be watery. One last thing: If you’d prefer a meat sauce, go ahead and brown a pound of ground beef after you sauté the onions and before you add the tomatoes – and expect the dish to feed more people that way. Makes: 8 servings Total carbohydrates: 15 grams per serving Active Time: 50 minutes Total Time: 1 ½ hours Ingredients 3 medium-sized zucchinis (around 1 pound) 2 teaspoons kosher salt (or 1 teaspoon table salt), divided, plus more as needed ¼ cup olive oil 1 onion, finely chopped 3 cloves garlic, finely chopped (or 1 teaspoon garlic powder) 1 (28-ounce) can tomato purée or crushed tomatoes Black pepper 1 (16-ounce) container whole-milk ricotta ½ cup heavy cream ½ cup grated Parmesan ¼ teaspoon nutmeg 1 pound whole-milk mozzarella, grated, sliced, or diced Instructions
A bouquet of pink and yellow tulips and a happy mother 's day card on a pink background.
By Gestational Type 1 Type 2 May 6, 2025
With Mother’s Day around the corner, now’s the time to find the perfect gift. From foot massagers and Fitbits to diabetes-friendly treats, our gift guide has something for every mom. Looking to show your mom or another MWD (mom with diabetes) how much you appreciate them? Rest easy – diaTribe has hand-picked 12 great diabetes gifts for Mother’s Day. To make sure these presents pass the all-important reality check, we consulted some MWDs in the know, including Jennifer Smith. Working primarily with women as the director of lifestyle and nutrition at Integrated Diabetes Services, Smith has type 1 diabetes and is a mother of two boys. What is her key to nailing a Mother's Day gift for someone with diabetes? “You have to know the person,” said Smith. “And the gift might have nothing to do with diabetes.”  If you want even more selection, check out diaTribe’s roundup of thoughtful gifts for people with diabetes . Or, just get scrolling.
By Gestational Type 1 Type 2 April 29, 2025
Whether you use syringes or insulin pens, injections can be a pain – literally. Here are techniques and tips to make injections as seamless as possible. There are many ways to take insulin , including syringes, prefilled pens, or insulin pumps. How you take insulin is highly personal – different people have different dosage needs, timing, and preferences. If you take insulin through injections, it’s important to choose and rotate injection sites properly and follow recommended steps to ensure safety. For the first time since 2016, experts from the Forum for Injection Technique and Therapy Expert Recommendations (FITTER) have updated recommendations on how to inject insulin correctly. Here, we cover the key updates and offer helpful tips to make injections a breeze. 
April 15, 2025
With so many things happening in the diabetes tech world, it can be hard to keep up. Stay up to date here with the latest diabetes tech news and alerts.
April 10, 2025
Type 2 diabetes, a condition marked by chronically high blood sugar levels, is a leading driver of metabolic disease in America. While conventional medical advice recommends taking medications to control blood sugar levels, this is only a temporary measure at best.  Diabetes is compounded by several factors, and recent research notes that nutritional deficiencies is a commonly overlooked aspect, and that when these deficiencies are addressed, managing and controlling this disease becomes easier.
March 24, 2025
Telemedicine can make diabetes care less expensive and easier to access, but it may not always be a suitable replacement for an in-person visit. Learn what happens during a telehealth visit and see if you could benefit from using telemedicine for your diabetes care. The pandemic upended a lot about life as we knew it. Notably, it was responsible for a 63-fold increase in telehealth visits . For people managing diabetes, however, having a doctor visit over video brings up a host of questions and potential issues. How can a doctor properly check my eyes and feet through a computer screen? Will telehealth replace in-person discussions about my blood sugar? Will I get the same level of care through a computer? According to a 2022 article in American Family Physician , telehealth is promising for diabetes treatment and has been shown to help improve glucose management. In a separate analysis of glucose data from people with type 2 diabetes, people who received remote monitoring of their glucose levels saw significant improvements in A1C over a period of three months. That being said, no study or physician is implying that telehealth fully replaces in-person medical care for diabetes. Here’s what to consider and who might be the best candidates for telediabetes care. What happens during a diabetes telehealth visit? Telediabetes care involves two types of interactions. One is a video meeting with a physician or care team to discuss challenges and potential solutions. During this type of visit, the healthcare provider can see some physical signs or changes, such as rashes or wounds. The second type of interaction is virtual monitoring of glucose levels through a monitoring device that sends data to the care provider. The provider might also follow up with a video call to discuss the data. “Many of the things that are important for diabetes care – blood glucose data review, medication review, insulin teaching – can all happen over video,” said Dr. Varsha Vimalananda, an endocrinologist and associate professor of medicine at Boston University. “CGM data can be uploaded and reviewed remotely, which is also very helpful.” Different providers use different video platforms for telehealth appointments, but most will look and function much like a Zoom call. The benefits of telehealth in diabetes care Not all elements of diabetes care are best suited for telehealth, but many lend themselves naturally to the conversation and convenience that an electronic visit facilitates. For type 2 diabetes in particular, telehealth has been shown to be more effective than in-person care at helping people manage their condition. One reason for the improved outcomes is simply better access to care. Dr. Keta Pandit, an endocrinologist at Texas Diabetes & Endocrinology in Austin, Texas, says continuous glucose monitoring (CGM), along with telehealth options, have changed the landscape of diabetes care. “One of the benefits of being able to offer telemedicine to our patient population is that it has increased the access to care, especially with any ongoing illnesses, hospitalizations, COVID, post-COVID, or any other situations when patients notice their glucose levels are going out of their standard range. Patients often contact us for these types of situations, and we can quickly get them seen via telemedicine to make adjustments to their diabetes medications,” she says. “While this was still an option prior to telemedicine days, the opportunity to see their provider on short notice, not having to worry about transportation, and not having to put in advance notice to take time off of work to travel to the doctor’s office, are some of the ways access to care has increased.” Pandit says this is particularly true for older patients who require frequent visits and women who are pregnant, as well as those who need to optimize their glucose levels before and after surgery. Jasmine Meidas, 51, of Cleveland, Ohio, is one such patient. She was diagnosed with type 2 diabetes 15 years ago. “During the COVID-19 pandemic, I was much more comfortable with telehealth than going into my endocrinologist’s office, which is in a hospital. I still am,” she says. Meidas has a one-hour telehealth visit every three months. “They can order blood work to be taken locally, [and] we review [the results] together. We also review food choices, lifestyle challenges, stressors, and more. We set action steps and goals for the next 90 days,” she says. Meidas periodically sees her endocrinologist in person as well. At Vimalananda’s clinic in Boston, specific groups are making great strides with telehealth options. “Veterans, mostly,” she says. “I have a few [Veteran patients] who have severe [post-traumatic stress disorder]. Driving out to the clinic, dealing with traffic, and navigating the hospital are all things that cause a lot of distress. It’s been a game-changer for them to be able to have the visit from home.” When is telehealth not the best option? “If you have diabetes, please remove your socks and shoes.” This type of sign is frequently displayed in doctors’ offices. How would a foot exam work in telehealth? This is a real concern for people with diabetes, as up to 15% of patients will have a foot ulcer in their lifetime. Pandit and other experts acknowledge the limitations telehealth can have. “The medical team [must depend] on the patient [to provide] data and limited access to other parameters that are needed, including blood pressure measurements or foot examinations. When visits are conducted via telemedicine…care is not as comprehensive,” says Pandit. “There are times when the telemedicine model may pose risks. The limitation is clearly noted in visits with patients who are not technologically savvy, may have hearing issues, or [have] poor [internet] connection at the time of the visit.” Telehealth can also give health care providers a direct view into the home environment, which may result in a patient’s hesitancy to share openly — with family members potentially nearby — and impede the building of relationships and rapport. For these reasons, Pandit recommends that at least every other visit be conducted in person. 
A logo for diabetic supplies inc. and eddy care
March 24, 2025
We are delighted to announce a groundbreaking partnership between Diabetic Supplies Inc. and eddii-Care , the virtual endocrine care clinic hosted by eddii—the leading diabetes management platform.
March 11, 2025
These protein- and fiber-packed spinach, ricotta, and mozzarella egg muffins are a filling yet healthy weekday breakfast option.
March 4, 2025
Key takeaways The FDA has issued a warning to users of continuous glucose monitors after reports of missed urgent blood sugar alarms on smartphones. Free apps can act as a backup for CGM alerts on your phone. A secondary alert system, like a CGM receiver or the SugarPixel standalone display, can ensure critical alerts are noticed. The FDA recently issued a safety notice after receiving reports from CGM users who missed critical low and high blood sugar alerts on their smartphones. Some of the causes for the missed alerts included: changes to phone settings, operating system upgrades, and using Bluetooth accessories. The safety warning coincided with my own experience. Following an update to my smartphone, I missed two critical low blood sugar alerts during the night. After missing those notices, I realized that I could back up my CGM alarms the same way I back up photos on my phone or laptop's hard drive. I then went about researching and testing other backup options, including these apps and devices I now use to make sure alarms are heard consistently, especially at night.
February 12, 2025
Marcia Kadanoff, who lives with type 2 diabetes, shares her top five tips for enjoying a Valentine’s Day meal out. Pink and red hearts everywhere, overpriced dinners, wondering if you’ll have a date (or if you got your partner an appropriate gift) – ah, the joys of Valentine’s Day. I’m stressed just thinking about it. As a person with diabetes, my stress may be a bit different than general Valentine’s Day anxiety. By this point, my spouse knows enough not to get me chocolates, my biggest landmine food. But the hard thing for Valentine's Day or any other romantic occasion is getting a reservation at the right kind of restaurant and – as always when living with diabetes – planning out my meal. Special occasion meals take special skills to navigate. The good news is that there are definitely strategies that can help make a romantic dinner somewhere special enjoyable without diabetes taking center stage. Where I live – the San Francisco Bay Area – many restaurants have Valentine’s Day dinner specials that consist of three to five courses. There’s nothing wrong with eating a multi-course meal, but it does make diabetes management more difficult. From bread to creamy soups and crouton-laden salads to heavy entrées to a dessert that’s potentially cake-filled, multi-course meals can quickly add up to a large amount of carbohydrates, which is a major driver of high blood sugars. The reality is that even if I choose the “healthier” set menu for a celebratory multi-course meal, I still make a point to think about what each portion is bringing (quite literally) to the table. Here are my best tips for navigating a Valentine's Day dinner out.
More Posts